KRROKorro Bio, Inc.
12.19USD+4.99%Mkt Cap: 175.52M USDP/E: Last update: 2026-05-26

Korro Bio, Inc., a biopharmaceutical company, engages in the discovering, developing, and commercializing of genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases in the United St…

Indicators:|

Key Statistics

Company
Market Cap175.52M USD
Enterprise Value90.45M USD
Revenue (TTM)3.84M USD
Gross Profit-45.40M USD
Net Income (TTM)-117.26M USD
Revenue/Share0.3860 USD
Last Price12.19 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees49
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN
Valuation
P/E (Trailing)
P/E (Forward)-2.21
PEG
EV/EBITDA-1.14
EV/Revenue23.54
P/S42.04
P/B1.35
EPS (TTM)-11.68
EPS (Forward)-5.06
52W Range
5.20414% of range55.89
52W High55.89 USD
52W Low5.204 USD
Profitability
Gross Margin0.00%
Oper. Margin-2154.03%
EBITDA Margin0.00%
Profit Margin-1834.48%
ROE-227.96%
ROA-103.31%
Growth
Revenue Growth
Earnings Growth
Cash Flow & Leverage
Operating CF-78.56M USD
CapEx (TTM)518.00K USD
FCF Margin-1016.09%
FCF Yield-22.24%
Net Debt-71.08M USD
Net Debt/EBITDA0.90
Balance Sheet
Debt/Equity0.85
Current Ratio8.13
Quick Ratio7.71
Book Value/Sh8.295 USD
Cash/Share7.902 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Splits
Last Split1:50
Split DateNov 6, 2023
Analyst Consensus
Rating1.4 (Strong Buy)
Target (Mean)19.89 USD
Target Range8.000 USD30.00 USD
# Analysts9
Ownership
Shares Out.14.42M
Float9.36M
Insiders0.57%
Institutions100.63%
Short Interest
Short Ratio7.3d
Short % Float8.70%
Short % Out.7.75%
Shares Short1.12M
Short (prev mo.)1.06M
Technical
SMA 5012.28 (-0.7%)
SMA 20018.44 (-33.9%)
Beta2.23
S&P 52W Chg28.31%
Avg Vol (30d)106.87K
Avg Vol (10d)146.67K
Technical Indicators
RSI (14)
MACD
MACD Signal
MACD Hist.
BB Upper
BB Middle
BB Lower
BB Width
ATR (14)
Vol Ratio (20d)